Medical Director, ADHD

Overview

Description

Tris Pharma, Inc. () is a leading privately-owned U.S. biopharmaceutical company with a focus on development and commercialization of innovative medicines in ADHD, spectrum disorders, anxiety, pain and addiction addressing unmet patient needs. We have >150 US and International patents and market several branded ADHD products in the U.S. We also license our products in the US and ex-US markets. We have a robust pipeline of innovative products spanning neuroscience and other therapeutic categories employing our proprietary science and technology.

Our science and technology make us unique, but our team members set us apart; they are the engine fueling Tris' passion and innovation. Our colleagues understand the criticality of operating a successful business and take pride in the company s success. Equally importance to each team member is how we interact with one another on a daily basis. We believe in each other and in respectful, open and honest communications to help support individual and team success.

We have an immediate opening in our Medical Affairs department in Monmouth Junction, NJ for an experienced Medical Director.

The Medical Director, ADHD serves as a key leader within the medical affairs team, overseeing the medical and scientific strategy for the company s ADHD pharmaceutical portfolio. This position acts as the medical and scientific authority in the ADHD therapeutic area and works cross-functionally with Commercial, Regulatory, R&D, Market Access, and other internal departments.

The Medical Director plays a pivotal role in the planning, execution, and oversight of Phase IV/IIS trials, medical communication, and stakeholder engagement specific to ADHD. This position also serves as a senior liaison with global healthcare providers, regulatory agencies, researchers, and key opinion leaders (KOLs) in ADHD, contributing to both the strategic direction and operational excellence of the organization.